BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 30962295)

  • 1. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
    Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
    Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
    Amaral T; Leiter U; Garbe C
    Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in Merkel cell carcinoma.
    Del Marmol V; Lebbé C
    Curr Opin Oncol; 2019 Mar; 31(2):72-83. PubMed ID: 30694842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for Merkel Cell Carcinoma.
    Nagase K; Narisawa Y
    Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
    Colunga A; Pulliam T; Nghiem P
    Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma.
    Gaiser MR; Bongiorno M; Brownell I
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):345-359. PubMed ID: 29478343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel Cell Carcinoma Therapeutic Update.
    Cassler NM; Merrill D; Bichakjian CK; Brownell I
    Curr Treat Options Oncol; 2016 Jul; 17(7):36. PubMed ID: 27262710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern diagnostics and treatment of Merkel cell carcinoma.
    Weilandt J; Peitsch WK
    J Dtsch Dermatol Ges; 2023 Dec; 21(12):1524-1546. PubMed ID: 37875785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avelumab: a new standard for treating metastatic Merkel cell carcinoma.
    Baker M; Cordes L; Brownell I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):319-326. PubMed ID: 29482384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Non-melanoma Skin Cancer.
    Shalhout SZ; Emerick KS; Kaufman HL; Miller DM
    Curr Oncol Rep; 2021 Aug; 23(11):125. PubMed ID: 34448958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Insights and Advances in the Management of Merkel Cell Carcinoma.
    Banks PD; Sandhu S; Gyorki DE; Johnston ML; Rischin D
    J Oncol Pract; 2016 Jul; 12(7):637-46. PubMed ID: 27407160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts and approaches to merkel cell carcinoma.
    Babadzhanov M; Doudican N; Wilken R; Stevenson M; Pavlick A; Carucci J
    Arch Dermatol Res; 2021 Apr; 313(3):129-138. PubMed ID: 32666149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
    Paulson KG; Bhatia S
    J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma.
    Samimi M
    Am J Clin Dermatol; 2019 Jun; 20(3):391-407. PubMed ID: 30784027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merkel Cell Carcinoma of Unknown Primary Origin.
    Francetić H; Simetić L; Tomasović Lončarić Č; Štulhofer Buzina D; Čeović R
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):153-155. PubMed ID: 38439727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune checkpoint inhibition in Merkel cell carcinoma].
    Terheyden P; Mohr A; Langan EA
    Hautarzt; 2019 Sep; 70(9):684-690. PubMed ID: 31468071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Merkel Cell Carcinoma.
    Harms PW
    Clin Lab Med; 2017 Sep; 37(3):485-501. PubMed ID: 28802497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.
    Schadendorf D; Lebbé C; Zur Hausen A; Avril MF; Hariharan S; Bharmal M; Becker JC
    Eur J Cancer; 2017 Jan; 71():53-69. PubMed ID: 27984768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Study of Ipilimumab Plus Nivolumab in Anti-PD-L1/PD-1 Refractory Merkel Cell Carcinoma.
    Shalhout SZ; Emerick KS; Kaufman HL; Silk AW; Thakuria M; Miller DM
    J Immunother; 2022 Sep; 45(7):299-302. PubMed ID: 35877101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
    Akaike T; Nghiem P
    J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.